Gastrin-releasing peptide receptor (GRPR) is overexpressed in over 75% of breast cancers and can be efficiently targeted with 177Lu-Bombesin to deliver therapeutic radiation doses to malignant cells. The gene discussed is GRPR; the disease is breast cancer.